Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125125812 | 12512581 | 2 | F | 201304 | 20160711 | 20160630 | 20160912 | PER | US-JNJFOC-20160505269 | JANSSEN | 73.54 | YR | E | M | Y | 0.00000 | 20160912 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125125812 | 12512581 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 15 | MG | TABLET | |||||
| 125125812 | 12512581 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 15 | MG | TABLET | |||||
| 125125812 | 12512581 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 15 | MG | TABLET | |||||
| 125125812 | 12512581 | 4 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 15 | MG | TABLET | |||||
| 125125812 | 12512581 | 5 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 15 | MG | TABLET | |||||
| 125125812 | 12512581 | 6 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 15 | MG | TABLET | |||||
| 125125812 | 12512581 | 7 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 15 | MG | TABLET | |||||
| 125125812 | 12512581 | 8 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 15 | MG | TABLET | |||||
| 125125812 | 12512581 | 9 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 15 | MG | TABLET | |||||
| 125125812 | 12512581 | 10 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 15 | MG | TABLET | |||||
| 125125812 | 12512581 | 11 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 15 | MG | TABLET | |||||
| 125125812 | 12512581 | 12 | PS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 202439 | 15 | MG | TABLET | |||||
| 125125812 | 12512581 | 13 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | Y | 0 | TABLET | |||||||||
| 125125812 | 12512581 | 14 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | Y | 0 | 81 | MG | TABLET | |||||||
| 125125812 | 12512581 | 15 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | Y | 0 | TABLET | |||||||||
| 125125812 | 12512581 | 16 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | Y | 0 | TABLET | |||||||||
| 125125812 | 12512581 | 17 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | Y | 0 | TABLET | |||||||||
| 125125812 | 12512581 | 18 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | Y | 0 | 81 | MG | TABLET | |||||||
| 125125812 | 12512581 | 19 | SS | LOVENOX | ENOXAPARIN SODIUM | 1 | Unknown | U | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125125812 | 12512581 | 1 | Pulmonary embolism |
| 125125812 | 12512581 | 2 | Pulmonary embolism |
| 125125812 | 12512581 | 3 | Pulmonary embolism |
| 125125812 | 12512581 | 4 | Atrial fibrillation |
| 125125812 | 12512581 | 5 | Atrial fibrillation |
| 125125812 | 12512581 | 6 | Atrial fibrillation |
| 125125812 | 12512581 | 7 | Thrombosis prophylaxis |
| 125125812 | 12512581 | 8 | Thrombosis prophylaxis |
| 125125812 | 12512581 | 9 | Thrombosis prophylaxis |
| 125125812 | 12512581 | 10 | Cerebrovascular accident prophylaxis |
| 125125812 | 12512581 | 11 | Cerebrovascular accident prophylaxis |
| 125125812 | 12512581 | 12 | Cerebrovascular accident prophylaxis |
| 125125812 | 12512581 | 13 | Anticoagulant therapy |
| 125125812 | 12512581 | 14 | Anticoagulant therapy |
| 125125812 | 12512581 | 15 | Anticoagulant therapy |
| 125125812 | 12512581 | 16 | Pulmonary embolism |
| 125125812 | 12512581 | 17 | Pulmonary embolism |
| 125125812 | 12512581 | 18 | Pulmonary embolism |
| 125125812 | 12512581 | 19 | Pulmonary embolism |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125125812 | 12512581 | OT |
| 125125812 | 12512581 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125125812 | 12512581 | Gastrointestinal haemorrhage | |
| 125125812 | 12512581 | Implant site haematoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125125812 | 12512581 | 1 | 20140522 | 0 | ||
| 125125812 | 12512581 | 2 | 20130128 | 201304 | 0 | |
| 125125812 | 12512581 | 3 | 201407 | 20140729 | 0 | |
| 125125812 | 12512581 | 4 | 20130128 | 201304 | 0 | |
| 125125812 | 12512581 | 5 | 201407 | 20140729 | 0 | |
| 125125812 | 12512581 | 6 | 20140522 | 0 | ||
| 125125812 | 12512581 | 7 | 20130128 | 201304 | 0 | |
| 125125812 | 12512581 | 8 | 201407 | 20140729 | 0 | |
| 125125812 | 12512581 | 9 | 20140522 | 0 | ||
| 125125812 | 12512581 | 10 | 20140522 | 0 | ||
| 125125812 | 12512581 | 11 | 20130128 | 201304 | 0 | |
| 125125812 | 12512581 | 12 | 201407 | 20140729 | 0 | |
| 125125812 | 12512581 | 13 | 201408 | 0 | ||
| 125125812 | 12512581 | 14 | 20140522 | 0 | ||
| 125125812 | 12512581 | 15 | 201405 | 20140729 | 0 | |
| 125125812 | 12512581 | 16 | 201405 | 20140729 | 0 | |
| 125125812 | 12512581 | 17 | 201408 | 0 | ||
| 125125812 | 12512581 | 18 | 20140522 | 0 | ||
| 125125812 | 12512581 | 19 | 201407 | 201407 | 0 |